2 Wall Street Analysts Think Vertex Pharmaceuticals Stock Can Soar Another 20% or More Over the Next 12 Months. Here's Why They're Right.

Verdict

Headline leans bullish. We score VRTX +0.90 across four claims.

Score confirms the headline.

Headline says

Leans bullish

From its wording — no explicit rating

=

Expected · VRTX

+0.90strongly bullish